Dr. Chani Traube, professor of pediatrics at Weill Cornell Medicine, has been awarded a $3.4 million grant from the National Institutes of Health for a clinical trial called Optimizing Pain Treatment in Children on Mechanical ventilation.
Cornell's newest interdisciplinary EEG lab could help faculty make breakthroughs in fields ranging from psychology to neurology to artificial intelligence.
Inhibiting an immune signaling protein may help preserve the protective layer surrounding nerve fibers in the brain during both Alzheimer’s disease and ordinary aging, a new study suggests.
An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study by scientists at Weill Cornell Medicine.
A new protocol can detect and remove fake data created by bots and humans attempting to enroll in online research studies, in order to prevent biased results and unwarranted payments to bad actors – the first such protocol specifically designed for data collected in rural communities.
Beneficial gut microbes and the body work together to fine-tune fat metabolism and cholesterol levels, according to a new preclinical study by investigators from Weill Cornell Medicine and the Boyce Thompson Institute at Cornell’s Ithaca campus.
The new injectable weight-loss drug reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with placebo.
Weill Cornell Medicine researchers have determined the full-length structure and function of a blood pressure-regulating hormone receptor, which may enable better drug targeting of the receptor for diseases such as hypertension and heart failure.